Back to Results
First PageMeta Content
Critical Path Institute / Autosomal dominant polycystic kidney / Polycystic kidney disease / Imaging biomarker / Cystic kidney disease / Biomarker / Chronic kidney disease / Clinical Data Interchange Standards Consortium / Autosomal recessive polycystic kidney / Medicine / Kidney diseases / Health


Microsoft Word - Pharsight Collaborates with Critical Path Institute_FINAL.doc
Add to Reading List

Document Date: 2014-02-20 17:49:57

Open Document

File Size: 33,63 KB

Share Result on Facebook

City

Tucson / Rockville / Phoenix / ST. LOUIS / /

Company

PKD Foundation / Tripos L.P. / C-Path / Pharsight / PKD Consortium / Clinical Data Interchange Standards Consortium / /

Event

Business Partnership / /

Facility

Emory University / Mayo Clinic / Critical Path Institute / Tufts University / University of Colorado Denver / About Critical Path Institute / /

IndustryTerm

biotechnology / scientific consulting services / pharmaceutical / advocacy / software / pharmaceutical firms / /

MedicalCondition

quantitative disease / ADPKD / end-stage renal disease / genetic disease / disease / Polycystic Kidney Disease / Autosomal Dominant Polycystic Kidney Disease / /

Organization

University of Colorado Denver / Critical Path Institute / Tufts University / Emory University / U.S. Food and Drug Administration / Tufts University School of Medicine / /

Person

Raymond Woosley / Ronald Perrone / Eslie Dennis / Jill Panetta / /

Position

active advisor / Executive Director / Co-Director / Interim Chief Executive Officer / Vice President and Lead Scientist / President and Chief Executive Officer / representative / international leader / Professor of Medicine / /

Product

Trademarks Pharsight / /

ProvinceOrState

Maryland / Arizona / /

Region

Southern Arizona / /

Technology

biotechnology / drug development / /

URL

www.pkdcure.org / www.pharsight.com / www.c-path.org / /

SocialTag